Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment.
Ontology highlight
ABSTRACT: Skin diseases are the fourth leading cause of nonfatal and chronic skin diseases, acting as a global burden and affecting the world economy. Skin diseases severely impact the patients' quality of life and have influenced their physical and mental state. Treatment of these skin disorders with conventional methods shows a lack of therapeutic efficacy, long treatment duration, recurrence of the condition, and systemic side effects due to improper drug delivery. However, these pitfalls can be overcome with the applications of advanced nanocarrier- and microneedle (MN)-based transdermal drug delivery strategies that provide efficient site-specific drug delivery at the target site. These advanced transdermal drug delivery strategies can be more effective than other drug administration routes by
SUBMITTER: Qu F
PROVIDER: S-EPMC9065205 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA